Clin2
NCT07152873Likely a fitNot yet recruiting

Comparing two versions of a study drug in healthy volunteers

Mixed Dyslipidemia

Part of Heart & circulation, Hormones & metabolism clinical trials.

This trial compares how the body processes two different forms of the same drug, AD-117 and AD-117A, and checks for safety. It's for healthy adults to help ensure the drug works similarly and safely.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
60 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You must be 19 years or older.
  • Your weight must be at least 50 kg (110 lbs) if male, or 45 kg (99 lbs) if female.
  • Your body mass index (BMI) must be between 18.0 and 30.0.
  • You must be generally healthy.
  • You cannot have taken part in another drug study in the last 6 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06932705Recruiting· Phase 1
Comparing PA-111 and PA-111A in healthy volunteers

This trial tests how two study drugs, PA-111 and PA-111A, are processed by the body and how safe they are. Healthy volunteers are needed to compare the two drugs.

Seoul
NCT06884098Recruiting· Phase 1
A study comparing two versions of a medicine in healthy adults

This trial tests a new version of a medicine (AD-228B) against the original (AD-2284) to see how they work in the body and if they are safe. Healthy volunteers are needed.

Seoul
NCT07581028Not yet recruiting· Phase 1
Comparing Two Versions of an Experimental Drug in Healthy Adults

This study tests whether two different formulations of an experimental medication (AJU-C715) work the same way in your body. Researchers will give you one version and then later the other version to compare how much of the drug enters your bloodstream and how long it stays there.

Seoul
NCT07590167Not yet recruiting· Phase 1
Safety Study of a New Drug Combination in Healthy Volunteers

This early-stage study tests a new investigational drug called AD-231 to see how safe it is and how your body processes it. Researchers will compare it to a combination of three related drugs to understand which approach works best.

Seoul
NCT07730567Not yet recruiting· Phase 1
Study of AD-236A and AD-236B interaction in healthy adults

This study tests how two experimental drugs, called AD-236A and AD-236B, interact in the body and checks if they are safe. Healthy volunteers are needed to see how the drugs affect each other.

Seoul
NCT07312773Not yet recruiting· Phase 1
Drug interaction and safety study in healthy adults

This trial tests whether three experimental drugs (AD-231A, AD-231B, and AD-231C) interact with each other and how safe they are. Healthy volunteers are needed to help understand how the body processes these drugs.

Seoul

Hear when a new Mixed Dyslipidemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.